BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19714252)

  • 1. Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer.
    Distler U; Souady J; Hülsewig M; Drmić-Hofman I; Haier J; Friedrich AW; Karch H; Senninger N; Dreisewerd K; Berkenkamp S; Schmidt MA; Peter-Katalinić J; Müthing J
    PLoS One; 2009 Aug; 4(8):e6813. PubMed ID: 19714252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity.
    Schweppe CH; Bielaszewska M; Pohlentz G; Friedrich AW; Büntemeyer H; Schmidt MA; Kim KS; Peter-Katalinić J; Karch H; Müthing J
    Glycoconj J; 2008 May; 25(4):291-304. PubMed ID: 18176841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation.
    Storck W; Meisen I; Gianmoena K; Pläger I; Kouzel IU; Bielaszewska M; Haier J; Mormann M; Humpf HU; Karch H; Müthing J
    Biol Chem; 2012 Aug; 393(8):785-99. PubMed ID: 22944681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry.
    Hoffmann P; Hülsewig M; Duvar S; Ziehr H; Mormann M; Peter-Katalinić J; Friedrich AW; Karch H; Müthing J
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2295-304. PubMed ID: 20623712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1.
    Meisen I; Friedrich AW; Karch H; Witting U; Peter-Katalinić J; Müthing J
    Rapid Commun Mass Spectrom; 2005; 19(24):3659-65. PubMed ID: 16285017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI-2 Mass Spectrometry and Immunohistochemistry Imaging of Gb3Cer, Gb4Cer, and Further Glycosphingolipids in Human Colorectal Cancer Tissue.
    Bien T; Perl M; Machmüller AC; Nitsche U; Conrad A; Johannes L; Müthing J; Soltwisch J; Janssen KP; Dreisewerd K
    Anal Chem; 2020 May; 92(10):7096-7105. PubMed ID: 32314902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Human Colon Epithelial Cells (pHCoEpiCs) Do Express the Shiga Toxin (Stx) Receptor Glycosphingolipids Gb3Cer and Gb4Cer and Are Largely Refractory but Not Resistant towards Stx.
    Detzner J; Püttmann C; Pohlentz G; Humpf HU; Mellmann A; Karch H; Müthing J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains.
    Betz J; Bielaszewska M; Thies A; Humpf HU; Dreisewerd K; Karch H; Kim KS; Friedrich AW; Müthing J
    J Lipid Res; 2011 Apr; 52(4):618-34. PubMed ID: 21252262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood-brain barrier endothelial cells.
    Legros N; Dusny S; Humpf HU; Pohlentz G; Karch H; Müthing J
    Glycobiology; 2017 Jan; 27(1):99-109. PubMed ID: 27558838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines.
    Kouzel IU; Pohlentz G; Schmitz JS; Steil D; Humpf HU; Karch H; Müthing J
    Toxins (Basel); 2017 Oct; 9(11):. PubMed ID: 29068380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells.
    Miyamoto D; Ueno T; Takashima S; Ohta K; Miyawaki T; Suzuki T; Suzuki Y
    Glycoconj J; 1997 Apr; 14(3):379-88. PubMed ID: 9147061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.
    Geyer PE; Maak M; Nitsche U; Perl M; Novotny A; Slotta-Huspenina J; Dransart E; Holtorf A; Johannes L; Janssen KP
    Mol Cancer Ther; 2016 May; 15(5):1008-17. PubMed ID: 26826119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer.
    Distler U; Souady J; Hülsewig M; Drmić-Hofman I; Haier J; Denz A; Grützmann R; Pilarsky C; Senninger N; Dreisewerd K; Berkenkamp S; Schmidt MA; Peter-Katalinic J; Müthing J
    Mol Cancer Ther; 2008 Aug; 7(8):2464-75. PubMed ID: 18723492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The liver flukes Fasciola gigantica and Fasciola hepatica express the leucocyte cluster of differentiation marker CD77 (globotriaosylceramide) in their tegument.
    Wuhrer M; Berkefeld C; Dennis RD; Idris MA; Geyer R
    Biol Chem; 2001 Feb; 382(2):195-207. PubMed ID: 11308018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, pathological and oncological relevance of Gb3Cer receptor.
    Đevenica D; Čikeš Čulić V; Vuica A; Markotić A
    Med Oncol; 2011 Dec; 28 Suppl 1():S675-84. PubMed ID: 21069478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells.
    Betz J; Bauwens A; Kunsmann L; Bielaszewska M; Mormann M; Humpf HU; Karch H; Friedrich AW; Müthing J
    Biol Chem; 2012 Mar; 393(3):133-47. PubMed ID: 22718629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Shiga toxin 2e glycosphingolipid receptors of primary porcine brain endothelial cells and toxin-mediated breakdown of the blood-brain barrier.
    Meisen I; Rosenbrück R; Galla HJ; Hüwel S; Kouzel IU; Mormann M; Karch H; Müthing J
    Glycobiology; 2013 Jun; 23(6):745-59. PubMed ID: 23431059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-step method for purification of Shiga toxin-1 B subunit using receptor-mediated affinity chromatography by globotriaosylceramide-conjugated octyl sepharose CL-4B.
    Nakajima H; Katagiri YU; Kiyokawa N; Taguchi T; Suzuki T; Sekino T; Mimori K; Saito M; Nakao H; Takeda T; Fujimoto J
    Protein Expr Purif; 2001 Jul; 22(2):267-75. PubMed ID: 11437603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific targeting of pancreatic cancer with Shiga toxin B-subunit.
    Maak M; Nitsche U; Keller L; Wolf P; Sarr M; Thiebaud M; Rosenberg R; Langer R; Kleeff J; Friess H; Johannes L; Janssen KP
    Mol Cancer Ther; 2011 Oct; 10(10):1918-28. PubMed ID: 21788400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.